Esketamine for treatment-resistant depression

Review notes that although esketamine offers a different pharmacological approach to management of treatment-resistant depression, there is limited long-term data on its safety and efficacy and a lack of evidence comparing it with existing options for managing the condition.

Source:

Drug and Therapeutics Bulletin